Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Immunotherapy and future directions in oncology

Immunotherapy and future directions in oncology Monoclonal antibody-based technologies have now been in use for decades targeting specific cancer cells to serve either as therapeutics (eg Genentech's trastuzumab, Herceptin) or invitro diagnostics (immunoassays) or to ... received prior treatment with

Roche says Tecentriq "off to a good start"

Roche says Tecentriq Strong gains for Perjeta (pertuzumab) and Kadcyla (ado-trastuzumab emtansine) reinforced a 5% increase for HER2 stalwart Herceptin (trastuzumab) to 3.4bn francs.

Novartis gets FDA panel backing for biosimilar Enbrel

Novartis gets FDA panel backing for biosimilar Enbrel The Japanese drugmaker gains exclusive commercialisation rights to nine drugs in Amgen's biosimilar pipeline, including its Humira clone and copies of Roche's anticancer drugs Avastin (bevacizumab) and Herceptin (trastuzumab).

Lilly and Boehringer combine breast cancer drugs in trial

Lilly and Boehringer combine breast cancer drugs in trial Herceptin (trastuzumab).

European pharma ‘to grow 3.2% per year by 2022’

European pharma ‘to grow 3.2% per year by 2022’ Cancer treatments are set to provide five compounds in the top 10 in 2022, although Roche's Herceptin (2015 sales of 2.117 bn to 2022 sales of 1.383 bn) ... Among these is Mylan and Biocon's MYL-1401O, whose data was shown to be comparable in efficacy

[ Previous 5 results ] 9 10 11 12 13 14 15 16 17 18 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics